This study demonstrates that Netrin-1 and adiponectin exhibit opposing serum profiles across a metabolic spectrum—from non-obese individuals to those with preclinical obesity and clinical obesity + insulin resistance. Here, ADIPOQ is linked to obesity due to melanocortin 4 receptor deficiency.